Quinoxalin-2-carboxamides: Synthesis and pharmacological evaluation as serotonin type-3 (5-HT3) receptor antagonists

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 26, Issue 5, 2011, Pages 610-615

  Mahesh, Radhakrishnan ^a   Devadoss, Thangaraj ^a   Pandey, Dilip Kumar ^a   Yadav, Shushil Kumar ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

5 HT 3 receptor antagonists; Quinoxalin 2 carboxamides; Quinoxaline; Serotonin

Indexed keywords

(4 BENZYLPIPERAZIN 1 YL)(QUINOXALIN 2 YL)METHANONE; AMINE; QUINOXALIN 2 CARBOXAMIDE; QUINOXALINE DERIVATIVE; SEROTONIN 3 ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ILIAC BONE; MALE; MYENTERIC PLEXUS; NONHUMAN; PRIORITY JOURNAL; SPECTROSCOPY; STRUCTURE ANALYSIS;

ANIMALS; GUINEA PIGS; ILEUM; MOLECULAR STRUCTURE; MYENTERIC PLEXUS; ONDANSETRON; QUINOXALINES; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS;

CAVIA;

EID: 80052859579     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2010.543419     Document Type: Article

References (18)

1. 3-receptor antagonists in elderly cancer patients treated with chemotherapy. Ann Oncol 2004;15:987-988. (Pubitemid 39004358)
2. Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewin C, Fox RM, Tattersall MH. On the receiving end-patient perception of the side-efects of cancer chemotherapy. Eur J Cancer Clin Oncol 1983;19:203-208. (Pubitemid 13155858)
3. Hesketh PJ. Chemotherapy-induced nausea and vomiting. N Engl J Med 2008;358:2482-2494.
4. Jordan K, Schmoll HJ, Aapro MS. Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol 2007;61:162-175. (Pubitemid 46073781)
5. Craig JB, Powell BL. Te management of nausea and vomiting in clinical oncology. Am J Med Sci 1987;293:34-44. (Pubitemid 17040497)
6. Cubeddu LX. Mechanisms by which cancer chemotherapeutic drugs induce emesis. Semin Oncol 1992;19:2-13. (Pubitemid 23047122)
7. Jordan K, Sippel C, Schmoll HJ. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations. Oncologist 2007;12:1143-1150. (Pubitemid 350007026)
8. Ohtaka H, Fujita T., In: Jucker E, ed. Progress in Drug Research, Chap. 4, Vol. 41. Switzerland: Birkhauser Verlag Basel, 1993:338.
9. 3) receptor antagonist. Biol Pharm Bull 2004;27:1403-1405. (Pubitemid 41701683)
10. 3 receptor antagonists. J Med Chem 1993;36:2645-2657. (Pubitemid 23294131)
11. 3) receptor antagonists. I. Synthesis and structure-activity relationships of conformationally restricted fused imidazole derivatives. Chem Pharm Bull 1996;44:991-999. (Pubitemid 26194021)
12. 3 receptor antagonists. Bioorg Med Chem Lett 2006;16:2769-2772.
13. 3 receptor antagonists and a defnition of a model for this receptor site. J Med Chem 1990;33:1594-1600. (Pubitemid 20180616)
14. Paton WD, Zar MA. Te origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. J Physiol (Lond) 1968;194:13-33.
15. MacKay D. How should values of pA2 and afnity constants for pharmacological competitive antagonists be estimated? J Pharm Pharmacol 1978;30:312-313. (Pubitemid 8334359)
16. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Del Rev 1997;23:3-25. (Pubitemid 27046991)
17. Harms AE. An efcient synthesis of 2-quinoxalinecarboxylic acid. Org Process Res Dev 2004;8:666-669.
18. 3 receptor antagonists. Bioorg Med Chem Lett 2004;14:5179-5181. (Pubitemid 39233390)